Cargando…

Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study

INTRODUCTION: Diabetic nephropathy (DN) is a progressive kidney disease resulting as a complication of diabetes mellitus. This study evaluated the disease progression and economic burden of DN among commercially insured patients with type 2 diabetes in the USA. METHODS: The research design was a ret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Zhou, Chaudhari, Paresh, Yang, Hongbo, Fang, Anna P., Zhao, Jing, Law, Ernest H., Wu, Eric Q., Jiang, Ruixuan, Seifeldin, Raafat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446382/ https://www.ncbi.nlm.nih.gov/pubmed/28361464 http://dx.doi.org/10.1007/s13300-017-0256-5

Ejemplares similares

Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis
por: Jiang, Ruixuan, et al.
Publicado: (2018)

Medical Care Costs Associated With Progression of Diabetic Nephropathy
por: Nichols, Gregory A., et al.
Publicado: (2011)

Patient-Reported Utilization Patterns of Fentanyl Transdermal System and Oxycodone Hydrochloride Controlled-Release Among Patients With Chronic Nonmalignant Pain
por: Seifeldin, Raafat
Publicado: (2003)

Diabetic Retinopathy in Patients with Diabetic Nephropathy: Development and Progression
por: Jeng, Chi-Juei, et al.
Publicado: (2016)

Characteristics of diabetic nephropathy patients without diabetic retinopathy: A retrospective observational study
por: Li, Xiao-Qian, et al.
Publicado: (2017)

Urinary adiponectin and progression of diabetic nephropathy in type 1 diabetes
por: Ha, Kyoung Hwa, et al.
Publicado: (2015)

The Severity of Diabetic Retinopathy Is an Independent Factor for the Progression of Diabetic Nephropathy
por: Hsing, Shi-Chue, et al.
Publicado: (2020)

Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States
por: Durden, Emily, et al.
Publicado: (2013)

Intrarenal Dopamine Inhibits Progression of Diabetic Nephropathy
por: Zhang, Ming-Zhi, et al.
Publicado: (2012)

3-Hydroxybutyrate Ameliorates the Progression of Diabetic Nephropathy
por: Jung, Jeeyoun, et al.
Publicado: (2022)

The role of cellular crosstalk in the progression of diabetic nephropathy
por: Zhang, Keying, et al.
Publicado: (2023)

MicroRNA-21 as an Early Marker of Nephropathy in Patients with Type 1 Diabetes
por: Fouad, Mohamed, et al.
Publicado: (2020)

Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
por: Oudit, Gavin Y., et al.
Publicado: (2010)

Healthcare resource utilization and cost among patients with type 1 diabetes in the United States
por: Simeone, Jason C, et al.
Publicado: (2020)

Midkine: Utility as a Predictor of Early Diabetic Nephropathy in Children with Type 1 Diabetes Mellitus
por: Metwalley, Kotb Abbass, et al.
Publicado: (2021)

Albumin Antioxidant Response to Stress in Diabetic Nephropathy Progression
por: Medina-Navarro, Rafael, et al.
Publicado: (2014)

Biomarkers of progression in diabetic nephropathy: The past, present and future
por: Lee, Chi-Ho, et al.
Publicado: (2015)

G-CSF Prevents Progression of Diabetic Nephropathy in Rat
por: So, Byung-Im, et al.
Publicado: (2013)

Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy
por: Sun, Li‐Jing, et al.
Publicado: (2017)

Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy
por: Dai, Haoran, et al.
Publicado: (2017)

Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy
por: Zhang, Lili, et al.
Publicado: (2020)

Nanomedicines for the management of diabetic nephropathy: present progress and prospects
por: Paul, Paramita, et al.
Publicado: (2023)

The Signaling of Cellular Senescence in Diabetic Nephropathy
por: Xiong, Yabing, et al.
Publicado: (2019)

Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
por: Lin, Julie, et al.
Publicado: (2008)

Taurine Alleviates the Progression of Diabetic Nephropathy in Type 2 Diabetic Rat Model
por: Koh, Jang Hyun, et al.
Publicado: (2014)

Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes
por: Krolewski, Andrzej S.
Publicado: (2015)

Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice
por: Mashitah, Musthika Wida, et al.
Publicado: (2015)

A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients
por: Boulanger, Luke, et al.
Publicado: (2009)

Diabetic nephropathy
por: Zelmanovitz, Themis, et al.
Publicado: (2009)

Diabetic Nephropathy without Diabetes
por: López-Revuelta, Katia, et al.
Publicado: (2015)

Non-diabetic nephropathy in diabetics
Publicado: (2014)

Comparative analysis of diabetic nephropathy and non-diabetic nephropathy disease
por: Chen, Qiuxiang, et al.
Publicado: (2017)

Epigenetics in the pathogenesis of diabetic nephropathy: Epigenetics in the pathogenesis of diabetic nephropathy
por: Li, Xue, et al.
Publicado: (2021)

Adiponectin retards the progression of diabetic nephropathy in db/db mice by counteracting angiotensin II
por: Guo, Xiaohua, et al.
Publicado: (2014)

Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
por: Mu, Xiaodie, et al.
Publicado: (2022)

Astragalus–Saffron–Rhubarb Mixture Delays the Progress of Diabetic Nephropathy in db/db Mice
por: Zhou, Xiao-Chun, et al.
Publicado: (2021)

Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus
por: Song, Ki‐Ho, et al.
Publicado: (2018)

Environmental Lead Exposure Accelerates Progressive Diabetic Nephropathy in Type II Diabetic Patients
por: Huang, Wen-Hung, et al.
Publicado: (2013)

Therapeutic approaches to slowing the progression of diabetic nephropathy – is less best?
por: Vivian, Eva, et al.
Publicado: (2013)

Epidermal growth factor receptor signaling and the progression of diabetic nephropathy
por: Koya, Daisuke
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f21mvep6aue39oe0rgm8n02tqh